8-K: Intelligent Bio Solutions Engages C2C Advisors and ClearThink Capital for Investor Relations

Intelligent Bio Solutions Inc. has entered into agreements with C2C Advisors Inc. and ClearThink Capital LLC for advisory and investor relations services, involving cash payments and stock grants.

Summary

• Intelligent Bio Solutions Inc. has engaged C2C Advisors Inc. for advisory and investor relations services.
• The agreement with C2C Advisors includes a $25,000 monthly cash fee and a one-time grant of 37,500 restricted shares.
• The C2C agreement has an initial term of six months.
• Intelligent Bio Solutions also engaged ClearThink Capital LLC for similar services.
• The ClearThink agreement includes an initial grant of 5,260 restricted shares.
• ClearThink will also receive a $5,000 monthly cash fee and $4,000 worth of restricted stock per month, calculated quarterly.
• The ClearThink agreement can be terminated by either party after three months.
• Both stock grants are issued under an exemption from registration under the Securities Act of 1933.

Sentiment

Score: 6

Explanation: The document indicates a proactive approach to investor relations, which is generally positive. However, the financial commitment and potential dilution are moderate concerns.

Positives

• The company is actively seeking to improve its investor relations through these agreements.
• The agreements provide clear compensation structures for the consultants.
• The use of restricted stock aligns the consultants' interests with the company's long-term performance.

Negatives

• The company is incurring significant monthly cash expenses for these services.
• The issuance of restricted stock could potentially dilute existing shareholders.
• The agreements commit the company to these expenses for at least three to six months.

Risks

• The effectiveness of the advisory and investor relations services is not guaranteed.
• The company may not see a return on investment from these agreements.
• The issuance of restricted stock could negatively impact the share price if not managed carefully.

Future Outlook

The company has not provided any specific forward-looking statements beyond the terms of the agreements.

Management Comments

• The company has not provided any specific management comments in this document.

Industry Context

It is common for companies, especially those seeking to increase their visibility and market value, to engage investor relations firms. This move suggests Intelligent Bio Solutions is actively working to enhance its market presence.

Comparison to Industry Standards

• The use of a combination of cash and stock for compensation is a common practice in the investor relations industry.
• The specific amounts and terms of the agreements are within the typical range for similar services, but the value of the stock component will depend on the company's share price performance.
• Companies like ICR, FTI Consulting, and Edelman often provide similar services, and the terms of these agreements appear to be competitive with industry standards.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• The company's cash reserves will be impacted by the monthly payments.
• The company hopes to improve its market visibility and investor relations.

Next Steps

• C2C Advisors and ClearThink Capital will begin providing advisory and investor relations services.
• The company will issue the agreed-upon restricted shares.
• The company will make monthly cash payments to both firms.

Key Dates

Keywords

investor relations, consulting agreement, restricted stock, advisory services, corporate development, equity securities